Page 956 - Veterinary Immunology, 10th Edition
P. 956

Eosinophil Activation, 332
  VetBooks.ir            Eosinophil Degranulation and Mediators,



                         332








               LEARNING OBJECTIVES




                 After reading this chapter, you should be able to:

                 • Describe the structure, location and properties of mast cells, eosinophils, and
                   basophils.
                 • Explain how type I hypersensitivities result from type 2 immune responses

                   mediated by immunoglobulin E (IgE).
                 • Describe how mast cells respond to the binding of antigen to cell bound IgE.
                 • Describe the structure and properties of IgE.

                 • Discuss how allergic disease is caused by the release of inflammatory molecules
                   from mast cells, eosinophils, and basophils.
                 • List the major inflammatory molecules released by each of these cells.

                 • Describe the ways in which mast cell responses are regulated.
                 • Understand how these responses probably evolved as a specialized defensive
                   response against parasitic helminths and arthropods.

                 • Describe the pathways involved in the mobilization of eosinophils.
                 • Explain how these types of response are affected by the composition of the

                   intestinal microbiota.






               Pathologic lesions triggered by immune responses are called
               hypersensitivities. They are classified into four major types based
               on their pathogenic mechanisms. Type I hypersensitivity reactions
               are inflammatory responses that result from the release of the
               contents of mast cell, basophil, and eosinophil cytoplasmic

               granules. This granule release is triggered when antigens bind to
               immunoglobulin E (IgE) on the surface of mast cells or basophils.
               These granules contain a mixture of molecules that trigger

               inflammation and attract eosinophils (Fig. 29.1). This inflammation




                                                         956
   951   952   953   954   955   956   957   958   959   960   961